Platinum(II) complexes such as cisplatin, among a few others, are well-known anticancer metal-based drugs approved for clinical use. In spite of their wide acceptance, the respective chemotherapy is ...

aDepartment of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China bCAS Key Laboratory of Computational Biology, CAS-MPG Partner Institute for ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. To globally profile circRNAs, we employ ...

At the same time, we are also examining more closely the interaction of the mRNA specific initiation factors (eIF4A, eIF4B, eIF4F, eIF4H) with RNA. Both the characteristics of ideal RNAs for binding ...

Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Quebec 514 343-6910, Canada Department of Chemistry, Université de Montréal, Montréal, Quebec 514 343-6910, ...

Keywords: eukaryotic translation initiation factor 4H (eIF4H), iTRAQ, major depressive disorder, putative hydroxypyruvate isomerase (HYI), RNA binding motif 8A (RBM8A) ...

Putative hydroxypyruvate isomerase (HYI), eukaryotic translation initiation factor 4H (eIF4H), and RNA binding motif 8A (RBM8A) had statistically significant differences before and after treatment in ...

The pluripotent state is not solely governed by the action of the core transcription factors OCT4, SOX2, and NANOG, but also by a series of co‐transcriptional and post‐transcriptional events, ...

This work was supported by the National Science Foundation of China (Grants 91753125, 31270865, 31322019, and 31570804), the National Key Research and Development Program of China (2016YFA0100303), ...